User profiles for HIROSHI WATANABE

Hiroshi Watanabe

- Verified email at tmd.ac.jp - Cited by 16168

Hiroshi Watanabe

- Verified email at oist.jp - Cited by 4380

[HTML][HTML] Phosphatidylinositol 4-phosphate 5-kinase α is a downstream effector of the small G protein ARF6 in membrane ruffle formation

…, T Yokozeki, M Yamazaki, H Nakamura, H Watanabe… - Cell, 1999 - cell.com
Synthesis of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P 2 ], a signaling phospholipid, is
primarily carried out by phosphatidylinositol 4-phosphate 5-kinase [PI(4)P5K], which has …

[HTML][HTML] The dynamic genome of Hydra

…, C Guder, Y Nakamura, S Ozbek, H Watanabe… - Nature, 2010 - nature.com
The freshwater cnidarian Hydra was first described in 1702 1 and has been the object of
study for 300 years. Experimental studies of Hydra between 1736 and 1744 culminated in the …

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

H Watanabe, N Chopra, D Laver, HS Hwang… - Nature medicine, 2009 - nature.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal
inherited arrhythmia syndrome in which drug therapy is often ineffective. We discovered that …

Conversion of channelrhodopsin into a light-gated chloride channel

…, JS Wiegert, N Adeishvili, F Schneider, H Watanabe… - Science, 2014 - science.org
The field of optogenetics uses channelrhodopsins (ChRs) for light-induced neuronal activation.
However, optimized tools for cellular inhibition at moderate light levels are lacking. We …

Astaxanthin, a carotenoid with potential in human health and nutrition

…, H Goto, K Matsumoto, H Watanabe - Journal of natural …, 2006 - ACS Publications
Astaxanthin (1), a red-orange carotenoid pigment, is a powerful biological antioxidant that
occurs naturally in a wide variety of living organisms. The potent antioxidant property of 1 has …

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study …

…, T Nishimaki, W Takiyama, H Watanabe… - Journal of clinical …, 2003 - ascopubs.org
Purpose: We performed a multicenter randomized controlled trial to determine whether
postoperative adjuvant chemotherapy improves outcome in patients with esophageal squamous …

Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study

H Watanabe, N Tanabe, T Watanabe, D Darbar… - Circulation, 2008 - Am Heart Assoc
Background— The metabolic syndrome consists of a cluster of atherosclerotic risk factors,
many of which also have been implicated in the genesis of atrial fibrillation (AF). However, the …

[HTML][HTML] Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans

H Watanabe, TT Koopmann… - The Journal of …, 2008 - Am Soc Clin Investig
Brugada syndrome is a genetic disease associated with sudden cardiac death that is
characterized by ventricular fibrillation and right precordial ST segment elevation on ECG. Loss-of-…

[PDF][PDF] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene …

…, M Maemondo, Y Kimura, N Morikawa, H Watanabe… - J Clin …, 2006 - researchgate.net
… Akira Inoue, Takuji Suzuki, Tatsuro Fukuhara, Makoto Maemondo, Yuichiro Kimura,
Naoto Morikawa, Hiroshi Watanabe, Yasuo Saijo, and Toshihiro Nukiwa … Financial …

Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death

…, S Kääb, BM Beckmann, P Weeke, H Watanabe… - Nature …, 2013 - nature.com
Brugada syndrome is a rare cardiac arrhythmia disorder, causally related to SCN5A
mutations in around 20% of cases 1 , 2 , 3 . Through a genome-wide association study of 312 …